BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19436114)

  • 1. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
    Hanczko R; Fernandez DR; Doherty E; Qian Y; Vas G; Niland B; Telarico T; Garba A; Banerjee S; Middleton FA; Barrett D; Barcza M; Banki K; Landas SK; Perl A
    J Clin Invest; 2009 Jun; 119(6):1546-57. PubMed ID: 19436114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
    Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
    J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
    Perl A; Hanczko R; Telarico T; Oaks Z; Landas S
    Trends Mol Med; 2011 Jul; 17(7):395-403. PubMed ID: 21376665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.
    Qian Y; Banerjee S; Grossman CE; Amidon W; Nagy G; Barcza M; Niland B; Karp DR; Middleton FA; Banki K; Perl A
    Biochem J; 2008 Oct; 415(1):123-34. PubMed ID: 18498245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
    Winans T; Oaks Z; Choudhary G; Patel A; Huang N; Faludi T; Krakko D; Nolan J; Lewis J; Blair S; Lai Z; Landas SK; Middleton F; Asara JM; Chung SK; Wyman B; Azadi P; Banki K; Perl A
    J Autoimmun; 2023 Nov; 140():103112. PubMed ID: 37742509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
    Lee-Barber J; English TE; Britton JF; Sobreira N; Goldstein J; Valle D; Bjornsson HT
    JIMD Rep; 2019; 44():9-15. PubMed ID: 29923087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.
    Oaks Z; Patel A; Huang N; Choudhary G; Winans T; Faludi T; Krakko D; Duarte M; Lewis J; Beckford M; Blair S; Kelly R; Landas SK; Middleton FA; Asara JM; Chung SK; Fernandez DR; Banki K; Perl A
    Nat Metab; 2023 Jan; 5(1):41-60. PubMed ID: 36658399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
    Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
    Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of transaldolase deficiency.
    Perl A
    IUBMB Life; 2007 Jun; 59(6):365-73. PubMed ID: 17613166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.
    Banki K; Hutter E; Colombo E; Gonchoroff NJ; Perl A
    J Biol Chem; 1996 Dec; 271(51):32994-3001. PubMed ID: 8955144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
    Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis.
    Yang X; Liu Y; Li M; Wu H; Wang Y; You Y; Li P; Ding X; Liu C; Gong J
    Cell Death Dis; 2018 Feb; 9(3):264. PubMed ID: 29449537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
    Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
    Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase.
    Banki K; Hutter E; Gonchoroff NJ; Perl A
    J Biol Chem; 1998 May; 273(19):11944-53. PubMed ID: 9565623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.
    Lu XF; Zhou YJ; Zhang L; Ji HJ; Li L; Shi YJ; Bu H
    World J Gastroenterol; 2015 Jun; 21(21):6591-603. PubMed ID: 26074697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma.
    Wu YR; Lee YC; Li WM; Hsu WC; Lin HH; Chang LL; Huang AM; Jhan JH; Wu WJ; Li CC; Lee HY; Yeh HC; Ke HL
    Pathol Int; 2021 Jul; 71(7):463-470. PubMed ID: 33848380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transaldolase: from biochemistry to human disease.
    Samland AK; Sprenger GA
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1482-94. PubMed ID: 19401148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
    Heinrich PC; Morris HP; Weber G
    Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.